News


In the media

DNX Biopharmaceuticals Announces Collaboration With Lung Cancer Initiative at Johnson & Johnson

By JLABS

Read full story
Other news

Johnson & Johnson Innovation Names Swedish Medical Technology Company PExA Awardee in the Carcinogenic Exposure Meter Quickfire Challenge

By JLABS

Read full story
In the media

Talent for Good: "My Company Let Me Take a Month Off Work to Volunteer"

By Alice Oglethorpe

Read full story
In the media

Pharma Must Use Tax-Reform Windfall To Make More Drugs Or Face Backlash - Part II

By Standish Fleming

Read full story
In the media

J&J Launches First JLABS in Europe

By Disha Padmanabha

Read full story
Other news

Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic targets

By JLABS

Read full story
Other news

Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials

By JLABS

Read full story
In the media

J&J Opens First JLABS Site In Europe

By Lucie Ellis

Read full story
In the media

New report highlights New York City’s health tech and life science investment landscape

By Stephanie Baum

Read full story
In the media

J&J extends its JLABS incubator scheme to Europe

By Phil Taylor

Read full story
In the media

Belgium chosen for first J&J ‘JLABS’ incubator in Europe

By Andrew McConaghie

Read full story
Other news

Symic Bio Completes the MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Knee Osteoarthritis

By JLABS

Read full story
Other news

Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies

By JLABS

Read full story
Other news

Next stop, Europe! @JNJInnovation introduces @JLABS in Belgium

By JLABS

Read full story
In the media

Johnson & Johnson opens first European JLABS incubator

By Nick Paul Taylor

Read full story